ANXA5 and neoplasm: While the initiation of cisplatin and AnxA5-E7 treatment at 15 days after TC-1 tumor challenge could result in the initial control of TC-1 tumor, resurgence of tumor growth was observed at 35 days after tumor challenge, and only 40% of mice were still alive at 70 days after tumor challenge (Fig. 7b, c).